CIDO SpA ( Site 1509)

Temuco, Araucania 4810148

0 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer

Studies at this site

• A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) — Running, not enrolling